Document Detail


Late-onset Blueberry Muffin Lesions Following Recombinant Erythropoietin Administration in a Premature Infant.
MedLine Citation:
PMID:  23007340     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Recombinant erythropoietin is being used in premature population for anemia of prematurity. It is considered very safe in this population, although risks are still being evaluated. We report the first case of dermal erythropoiesis as a side effect of recombinant erythropoietin in an extremely prematurely born infant presenting with late-onset blueberry muffin lesions.
Authors:
Vishal Pandey; Krishna Dummula; Garth Fraga; Prabhu Parimi
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  34     ISSN:  1536-3678     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  534-5     Citation Subset:  IM    
Affiliation:
Departments of *Pediatrics, Division of Neonatology ‡Pathology, University of Kansas, School of Medicine †Neonatal Intensive Care Unit §Department of Pathology and Laboratory Medicine, University of Kansas Hospital, Kansas City, KS.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas.
Next Document:  Report of a young girl with MYH9 mutation and review of the literature.